Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04098601 · ClinicalTrials.gov registry record · NA

Inpatient Link to Addiction Recovery

A NA study of Substance Use Disorders, sponsored by Prisma Health-Upstate.

Completed
Registry status
NA
Development phase
103
Enrollment target
1
Study location

NCT04098601 is a NA study of Substance Use Disorders that has completed, run by Prisma Health-Upstate. The registered enrollment target is 103 participants, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04098601, a NA study of Substance Use Disorders, has completed, sponsored by Prisma Health-Upstate.

COMPLETED
Registry status
NA
Development phase
103 participants
Enrollment target
1
Study location

Study Summary

The objective of this proposal is to link inpatients to a certified peer support specialist through FAVOR-Greenville and determine the effectiveness of recovery coaching on patient outcomes.This study will evaluate the impact of initiating peer recovery coaching during SUD patients' hospitalization on engagement in recovery services, addiction severity, and quality of life compared to the current standard of care.

Conditions Studied

Interventions

  • BEHAVIORAL Recovery Coach Intervention

Study Locations (1)

South Carolina

  • Greenville Memorial Hospital - Greenville

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2018-04-19
Est. Completion 2019-12-30
Phase NA

Sponsor

Prisma Health-Upstate

67 total trials

What the Registry Record Tells You About NCT04098601

The ClinicalTrials.gov registry entry for NCT04098601 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (79% lower). The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which Recovery Coach Intervention is the first listed.

NCT04098601 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT04098601 about?

NCT04098601 is a clinical study titled "Inpatient Link to Addiction Recovery". The objective of this proposal is to link inpatients to a certified peer support specialist through FAVOR-Greenville and determine the effectiveness of recovery coaching on patient outcomes.This study will evaluate the impact of initiating peer recovery coaching during SUD patients' hospitalization ...

What is the current status of trial NCT04098601?

This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2018-04-19. Estimated completion is 2019-12-30.

What conditions does trial NCT04098601 study?

This clinical trial studies the following conditions: Substance Use Disorders.

What interventions are being tested in trial NCT04098601?

The interventions under investigation include: Recovery Coach Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04098601?

This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04098601 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.